Table 3.
Distribution of the study population stratified by cognitive and physical impairment and singular association with Pathological Amyloid PET
| N | % | O.R. | 95%CI | p* | |
|---|---|---|---|---|---|
| Altered CDT and NPI | 23 | 48.0 | 3.45 | 1.01–11.2 | 0.04 |
| Altered CDT and 4-m WS | 6 | 12.5 | 0.46 | 0.07–3.07 | 0.42 |
| Altered CDT and Low Grip Strength | 4 | 8.3 | 3.03 | 0.28–33.4 | 0.36 |
| Altered CDT and Low Physical Performance | 13 | 27.1 | 5.80 | 1.04–32.2 | 0.04 |
| Altered NPI and 4-m WS | 4 | 8.3 | 0.29 | 0.02–4.16 | 0.36 |
| Altered NPI and Low Grip Strength | 5 | 10.4 | 4.12 | 0.38–44.5 | 0.24 |
| Altered NPI and Low Physical Performance | 18 | 37.5 | 7.98 | 1.38–46.0 | 0.02 |
| Altered CDT and NPI and Low Physical Performance | 13 | 27.1 | 5.80 | 1.05–32.2 | 0.04 |
*p is expression of singular logistic regression analysis between MCI due to AD versus MCI not due to AD for each reported categories
Singular analysis was also adjusted for age, sex and years of school